TruNorth Capital Management LLC lessened its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 22.0% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 298 shares of the company’s stock after selling 84 shares during the quarter. TruNorth Capital Management LLC’s holdings in Clorox were worth $48,000 at the end of the most recent reporting period.
A number of other large investors have also recently added to or reduced their stakes in the business. Brooklyn Investment Group raised its position in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new stake in Clorox in the 3rd quarter valued at about $27,000. Continuum Advisory LLC lifted its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after buying an additional 138 shares during the last quarter. Asset Planning Inc purchased a new position in Clorox during the fourth quarter worth about $32,000. Finally, BankPlus Trust Department acquired a new stake in shares of Clorox during the fourth quarter valued at about $40,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts have recently commented on CLX shares. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and raised their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a report on Thursday, January 30th. Wells Fargo & Company raised their target price on Clorox from $157.00 to $161.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Finally, Evercore ISI boosted their price target on shares of Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. Four equities research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $158.21.
Clorox Trading Down 1.7 %
Shares of NYSE:CLX opened at $154.52 on Tuesday. The company has a market cap of $19.03 billion, a PE ratio of 42.22, a P/E/G ratio of 2.62 and a beta of 0.42. The company’s 50 day moving average is $157.53 and its two-hundred day moving average is $160.03. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52.
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the firm earned $2.16 EPS. Equities analysts predict that The Clorox Company will post 7.15 earnings per share for the current fiscal year.
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- EV Stocks and How to Profit from Them
- Finding Hidden Gems: Unconventional Penny Stock Investing
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Price Targets on NVIDIA Rise in Front of Earnings
- What is the FTSE 100 index?
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.